Tilray Brands (NASDAQ:TLRY) Trading Down 5.1% After Earnings Miss

Tilray Brands, Inc. (NASDAQ:TLRY)’s share price dropped 5.1% during trading on Wednesday following a weaker than expected earnings announcement. The company traded as low as $6.06 and last traded at $6.14. Approximately 5,561,215 shares were traded during mid-day trading, an increase of 52% from the average daily volume of 3,666,924 shares. The stock had previously closed at $6.47.

The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The firm had revenue of $206.73 million for the quarter, compared to the consensus estimate of $201.35 million. During the same period in the previous year, the business posted ($0.87) earnings per share.

More Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Roth/MKM upgraded TLRY from Neutral to Buy, citing the Q3 results as a rebound and assigning a $10 price target — a near-term catalyst that supports buying interest. Roth upgrade
• Positive Sentiment: Jefferies reiterated a Buy and kept a $24 price target, pointing to strong cannabis sales and improving fundamentals — a high-profile vote of confidence that can boost investor conviction. Jefferies reiteration
• Positive Sentiment: Product innovation in beverages: Shock Top (Tilray Beverages) launched “High Voltage,” a 9.6% ABV double wheat beer — demonstrates revenue diversification and new retail skus that could lift beverage sales over time. Shock Top product launch
• Neutral Sentiment: Sector/regulatory tailwind: reports that the FDA will not enforce some CBD regulations have lifted cannabis names broadly, supporting TLRY alongside peers. This is a positive industry backdrop but not a company-specific guarantee. FDA CBD enforcement story
• Neutral Sentiment: Q3 reported record revenue of ~$207M (up ~11% y/y) and Tilray reaffirmed its outlook — revenue growth and a clearer medium?term story underpin positive sentiment, but investors are parsing the quality of that growth. Q3 highlights / record revenue
• Negative Sentiment: EPS miss: TLRY reported Q3 EPS of ($0.24) vs. ($0.14) expected — the earnings miss and continued negative net margin raise near-term profitability concerns and explain some intraday weakness. Earnings call transcript
• Negative Sentiment: Analyst price target cut: ATB Cormark trimmed its target to $9 and moved to Sector Perform — a more cautious analyst view that can cap upside until margins and execution improve. ATB Cormark price target cut
• Negative Sentiment: Beverage segment weakness and margin pressure were flagged by analysts and some coverage, which helps explain why the stock earlier sold off even with record revenue — execution in beverages and margin recovery remain key risks. Sell-off despite record revenue

Wall Street Analyst Weigh In

TLRY has been the subject of a number of research analyst reports. ATB Cormark Capital Markets cut their price target on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a report on Thursday. Wall Street Zen upgraded shares of Tilray Brands from a “sell” rating to a “hold” rating in a report on Saturday, March 21st. Roth Mkm upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a report on Thursday. Zacks Research upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. Finally, TD Cowen reduced their price target on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Monday. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $11.20.

Hedge Funds Weigh In On Tilray Brands

Institutional investors and hedge funds have recently modified their holdings of the stock. Alpine Global Management LLC bought a new position in shares of Tilray Brands in the fourth quarter worth about $169,000. Voloridge Investment Management LLC bought a new position in Tilray Brands during the fourth quarter worth $824,000. Polymer Capital Management US LLC acquired a new position in Tilray Brands during the 4th quarter valued at $1,058,000. Engineers Gate Manager LP bought a new stake in Tilray Brands in the 4th quarter valued at $126,000. Finally, Schonfeld Strategic Advisors LLC boosted its holdings in Tilray Brands by 4.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock valued at $1,304,000 after purchasing an additional 6,182 shares during the period. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Brands Price Performance

The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.72 and a current ratio of 2.81. The company has a market capitalization of $763.14 million, a price-to-earnings ratio of -0.48 and a beta of 2.00. The firm’s 50-day simple moving average is $7.32 and its 200-day simple moving average is $10.23.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.